The Globe and Mail reports in its Wednesday, March 4, edition that Raymond James analyst Brian MacArthur, in response to Cameco's long-term agreement to supply uranium to the Government of India's Department of Atomic Energy, increased his share target to $180 from $175. The Globe's David Leeder writes in the Eye On Equities column that Mr. MacArthur continues to rate Cameco "outperform." Analysts on average target the shares at $167.13. Mr. MacArthur says in a note: "Cameco provides investors with lower-risk exposure to the uranium market given its diversification of sources. These sources are supported by a portfolio of long-term contracts that provide some downside protection in periods of depressed spot uranium prices, while maintaining optionality to higher uranium prices. In addition, Cameco has multiple operations curtailed that could be brought back should uranium prices increase. Cameco is also vertically integrated with fuel services, GLE and Westinghouse. Although the 2021 tax court decision applies only to the 2003, 2005 and 2006 tax years, we view it as a positive for Cameco given we believe it could be relevant in determining the outcome for other years and reduces risk related to the CRA dispute."